Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects

Yue Hua Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information

Haijun Lib Guangdong Raynovent Biotech Co., Ltd, Guangzhou, ChinaView further author information

Min Wua Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China

Hong Zhanga Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information

Yanhua Dinga Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information

Yun Pengb Guangdong Raynovent Biotech Co., Ltd, Guangzhou, ChinaView further author information

Xiaojiao Lia Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information

Zhenxiang Yuc Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, ChinaCorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window